Question 1

What are the potential side effects of SPH1188-11?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase I Study of SPH1188-11 in NSCLC clinical trial (NCT03231475). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase I Study of SPH1188-11 in NSCLC clinical trial (NCT03231475). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the treatment schedule look like?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase I Study of SPH1188-11 in NSCLC clinical trial (NCT03231475). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific tests or procedures I will need to undergo during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase I Study of SPH1188-11 in NSCLC clinical trial (NCT03231475). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my progress be monitored during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase I Study of SPH1188-11 in NSCLC clinical trial (NCT03231475). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Phase I Study of SPH1188-11 in NSCLC clinical trial (NCT03231475). Contact the study team or your healthcare provider for specific answers.

What this study is about